Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Interactions between cardiovascular and cerebrovascular disease.

Di Pasquale G, Urbinati S, Perugini E, Gambetti S.

Curr Treat Options Neurol. 2012 Dec;14(6):557-93. doi: 10.1007/s11940-012-0204-7.

PMID:
23096595
2.

Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H.

J Am Coll Cardiol. 2013 Jun 25;61(25):2551-6. doi: 10.1016/j.jacc.2013.03.035. Epub 2013 Apr 10.

3.

Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.

Shantsila E, Lip GY.

Cochrane Database Syst Rev. 2016 Sep 15;9:CD003333. [Epub ahead of print] Review.

PMID:
27629776
4.

Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.

Alli O, Doshi S, Kar S, Reddy V, Sievert H, Mullin C, Swarup V, Whisenant B, Holmes D Jr.

J Am Coll Cardiol. 2013 Apr 30;61(17):1790-8. doi: 10.1016/j.jacc.2013.01.061. Epub 2013 Feb 28.

5.

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.

Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D; PROTECT AF Investigators.

Circulation. 2013 Feb 12;127(6):720-9. doi: 10.1161/CIRCULATIONAHA.112.114389. Epub 2013 Jan 16.

6.

Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin.

Reddy VY, Akehurst RL, Armstrong SO, Amorosi SL, Brereton N, Hertz DS, Holmes DR Jr.

Europace. 2016 Jul;18(7):979-86. doi: 10.1093/europace/euv412. Epub 2016 Feb 2.

8.

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators.

Lancet. 2009 Aug 15;374(9689):534-42. doi: 10.1016/S0140-6736(09)61343-X. Erratum in: Lancet. 2009 Nov 7;374(9701):1596.

PMID:
19683639
9.

Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.

Seeger J, Bothner C, Dahme T, Gonska B, Scharnbeck D, Markovic S, Rottbauer W, Wöhrle J.

Clin Res Cardiol. 2016 Mar;105(3):225-9. doi: 10.1007/s00392-015-0910-8. Epub 2015 Aug 30.

PMID:
26318322
10.

Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.

Wiebe J, Bertog S, Franke J, Wettstein O, Lehn K, Hofmann I, Vaskelyte L, Sievert H.

Catheter Cardiovasc Interv. 2014 Apr 1;83(5):796-802. doi: 10.1002/ccd.25329. Epub 2014 Jan 8.

PMID:
24327462
11.

Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.

Holmes DR Jr, Doshi SK, Kar S, Price MJ, Sanchez JM, Sievert H, Valderrabano M, Reddy VY.

J Am Coll Cardiol. 2015 Jun 23;65(24):2614-2623. doi: 10.1016/j.jacc.2015.04.025.

12.

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY.

J Am Coll Cardiol. 2014 Jul 8;64(1):1-12. doi: 10.1016/j.jacc.2014.04.029. Erratum in: J Am Coll Cardiol. 2014 Sep 16;64(11):1186.

13.
14.

Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.

Swaans MJ, Alipour A, Rensing BJ, Post MC, Boersma LV.

J Vis Exp. 2013 Feb 26;(72):e3818. doi: 10.3791/3818.

15.

Left Atrial Appendage Closure Device With Delivery System: A Health Technology Assessment.

Health Quality Ontario .

Ont Health Technol Assess Ser. 2017 Jul 4;17(9):1-106. eCollection 2017.

16.

Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.

Grosset-Janin D, Barth E, Bertrand B, Detante O.

Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23. Review.

PMID:
25912470
17.

Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.

Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A, Ageno W; FORI (Foramen Ovale Registro Italiano) Investigators.

Cerebrovasc Dis. 2011;31(2):109-16. doi: 10.1159/000321334. Epub 2010 Nov 17.

PMID:
21088390
18.

Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.

Partington SL, Abid S, Teo K, Oczkowski W, O'Donnell MJ.

Thromb Res. 2007;120(5):663-9. Epub 2007 Apr 16.

PMID:
17434577
19.

The WATCHMAN left atrial appendage closure device for atrial fibrillation.

Möbius-Winkler S, Sandri M, Mangner N, Lurz P, Dähnert I, Schuler G.

J Vis Exp. 2012 Feb 28;(60). pii: 3671. doi: 10.3791/3671.

20.

Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation.

Ussia GP, Mulè M, Cammalleri V, Scarabelli M, Barbanti M, Immè S, Mangiafico S, Marchese A, Galassi AR, Tamburino C.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):217-22. doi: 10.1002/ccd.22099.

PMID:
19472361

Supplemental Content

Support Center